Cargando…

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway

Glutamine is one of the main nutrients used by tumor cells for biosynthesis. Therefore, targeted inhibition of glutamine metabolism may have anti-tumorigenic implications. In the present study, we aimed to evaluate the effects of glutamine on ovarian cancer cell growth. Three ovarian cancer cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Lingqin, Sheng, Xiugui, Willson, Adam K, Roque, Dario R, Stine, Jessica E, Guo, Hui, Jones, Hannah M, Zhou, Chunxiao, Bae-Jump, Victoria L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500469/ https://www.ncbi.nlm.nih.gov/pubmed/26045471 http://dx.doi.org/10.1530/ERC-15-0192

Ejemplares similares

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
por: Suri, Anuj, et al.
Publicado: (2016)

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015)

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2021)

Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice
por: Grace, Matthew R., et al.
Publicado: (2019)

Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
por: Han, Xiaoyun, et al.
Publicado: (2015)

The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention
por: Guo, Hui, et al.
Publicado: (2018)

Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion
por: Shanware, Naval P., et al.
Publicado: (2014)

Glutamine Availability Regulates the Development of Aging Mediated by mTOR Signaling and Autophagy
por: Zhou, Jiao, et al.
Publicado: (2022)

mTOR Controls Ovarian Follicle Growth by Regulating Granulosa Cell Proliferation
por: Yu, James, et al.
Publicado: (2011)

Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice
por: Ueda, Yo, et al.
Publicado: (2019)

Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway
por: Li, Ling, et al.
Publicado: (2019)

Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer
por: Deng, Boer, et al.
Publicado: (2023)

Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells
por: Kong, Weimin, et al.
Publicado: (2015)

mTOR-Dependent Cell Proliferation in the Brain
por: Ryskalin, Larisa, et al.
Publicado: (2017)

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
por: Zhang, Lu, et al.
Publicado: (2016)

The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation
por: Chen, Rui, et al.
Publicado: (2014)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system
por: Yamada, Daisuke, et al.
Publicado: (2019)

The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling
por: Yamashita, Alex Shimura, et al.
Publicado: (2020)

Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017)

The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth
por: Roque, Dario R., et al.
Publicado: (2021)

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
por: Wang, Jiandong, et al.
Publicado: (2014)

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway
por: HE, FAN, et al.
Publicado: (2014)

Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation
por: Wang, Baofeng, et al.
Publicado: (2021)

mTOR coordinates protein synthesis, mitochondrial activity and proliferation
por: Morita, Masahiro, et al.
Publicado: (2015)

Glutamine, MTOR and autophagy: a multiconnection relationship
por: Bodineau, Clément, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

The Role and Application of Sirtuins and mTOR Signaling in the Control of Ovarian Functions
por: Sirotkin, Alexander V.
Publicado: (2016)

Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway
por: Xie, Jinlin, et al.
Publicado: (2018)

Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Overview of Research into mTOR Inhibitors
por: Mao, Beibei, et al.
Publicado: (2022)

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
por: Lampa, Michael, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
por: Weng, Huixi, et al.
Publicado: (2021)

Inositol monophosphatase 2 promotes epithelial ovarian cancer cell proliferation and migration by regulating the AKT/mTOR signaling pathway
por: Ablimit, Tangnur, et al.
Publicado: (2022)

Ovarian Cancer and Glutamine Metabolism
por: Fasoulakis, Zacharias, et al.
Publicado: (2023)

Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
por: Harasawa, Makiko, et al.
Publicado: (2011)

TBCK Influences Cell Proliferation, Cell Size and mTOR Signaling Pathway
por: Liu, Yueli, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bsho2nj6ugtmv82a611odn13j3